News Headlines Article

Study Suggests a Cholesterol Pill Benefits Patients With Kidney Disease
New York Times

Patients with chronic kidney disease who took Vytorin, a cholesterol-lowering pill, had one-sixth fewer heart attacks, strokes or operations to unblock their arteries than patients taking a placebo, according to the results of a study presented on Saturday.

The main benefit was not in reducing the risk of heart attacks and related deaths but in reducing the artery operations and certain kinds of strokes, according to the data presented at a meeting of kidney specialists this weekend in Denver.